United Health Products, Inc.
United Health Products, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | 0 | - | 0 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Offering Costs | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Deferred Costs | 0 | 0 | 0 | - | - | - | 0 | 0 | - | - | 0 | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Settlement Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Accrued Bonuses Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 0 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Notes Payable | 0 | 0 | - | - | - | - | - | 0 | - | - | 0 | 0 | |||||
Loans Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Operating Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Debt Current | 1 | 1 | 1 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Derivative Liabilities | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Convertible Long Term Notes Payable | - | - | 0 | 1 | 1 | 1 | 1 | - | - | - | 0 | - | |||||
Liabilities | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Value | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 77 | 77 | 77 | 77 | 77 | 77 | 76 | 76 | 75 | 75 | 75 | 74 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -4 | -4 | -4 | -3 | -3 | -3 | -2 | -2 | -2 | -2 | -2 | -2 | |||||
Retained Earnings Accumulated Deficit | -82 | -82 | -81 | -81 | -81 | -80 | -79 | -78 | -78 | -77 | -77 | -76 | |||||
Common Stock Share Subscribed But Unissued Subscri… | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 262 | 259 | 259 | 259 | 257 | 257 | 252 | 250 | 248 | 247 | 245 | 242 | |||||
Shares Outstanding | 262 | 259 | 259 | 259 | 257 | 257 | 252 | 250 | 248 | 247 | 245 | 242 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.54% | -9.23% | -26.15% | - | - | - | - | - | - | - | - | - |
| 2025 | -8.56% | -53.60% | -63.96% | -18.60% | -25.58% | -36.05% | -4.76% | -12.70% | 0.00% | 7.81% | 0.00% | -7.81% |
| 2024 | 8.57% | -5.71% | 4.57% | 12.00% | -14.00% | -20.00% | -30.93% | -37.11% | -27.84% | 4.08% | -3.67% | -48.16% |
| 2023 | - | - | - | - | - | - | -5.45% | -20.00% | -16.36% | -14.29% | -20.48% | -19.05% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.02 | 0.01 | 0.03 | 0.02 | 0.01 | 0.02 | 0.12 | 0.03 | 0.01 | 0.07 | 0.08 | 0.07 | |||||
| Quick Ratio | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.10 | 0.02 | 0.01 | 0.04 | 0.05 | 0.04 | |||||
| Working Capital | -4.12M | -4.14M | -3.84M | -1.96M | -1.88M | -1.77M | -1.45M | -2.17M | -2.06M | -1.86M | -1.80M | -1.92M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.06 | -1.06 | -1.08 | -1.03 | -1.02 | -1.04 | -1.11 | -1.07 | -1.06 | -1.13 | -1.17 | -1.19 | |||||
| Interest Coverage TTM | -30.32 | -18.50 | -40.43 | -49.77 | -89.72 | -201.74 | -87.90 | -53.98 | -44.20 | -45.17 | -59.90 | -59.61 | |||||
| Debt Ratio | 18.92 | 17.85 | 13.24 | 36.41 | 39.88 | 28.31 | 10.05 | 15.02 | 17.46 | 8.70 | 7.02 | 6.31 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | - | - | - | -100.00% | -100.00% | -100.00% | -100.00% | |||||
| Net Income Growth (1Y) | -52.02% | -52.83% | 33.35% | 77.55% | 60.98% | 59.45% | -23.69% | -41.07% | 21.98% | 3.57% | 55.45% | 12.83% | |||||
| EPS Growth (1Y) | -52.80% | -53.11% | 30.11% | 71.34% | 55.29% | 53.07% | -26.00% | -42.99% | 18.48% | -0.73% | 46.62% | 7.67% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -10.48 | -8.36 | -5.33 | -7.02 | -8.51 | -21.53 | -6.68 | -19.56 | -22.24 | -25.67 | -20.53 | -20.92 | |||||
| P/B TTM | -3.36 | -2.90 | -3.67 | -6.20 | -7.90 | -23.23 | -5.47 | -15.37 | -20.45 | -27.62 | -31.41 | -33.05 | |||||
| Market Cap | 14.91M | 12.16M | 14.23M | 20.70M | 25.22M | 66.34M | 13.38M | 32.45M | 40.96M | 49.61M | 53.85M | 58.92M | |||||
| Enterprise Value | 16.21M | 13.47M | 14.69M | 21.60M | 26.07M | 66.98M | 13.91M | 32.77M | 41.15M | 49.74M | 53.96M | 59.05M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -950.64K | -997.31K | -1.19M | -815.25K | -959.89K | -1.06M | -1.19M | -1.59M | -1.87M | -2.06M | -2.20M | -1.84M | |||||
| Net Debt | 1.30M | 1.31M | 458.27K | 909.12K | 847.28K | 642.59K | 532.04K | 313.72K | 188.75K | 126.62K | 112.08K | 130.71K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
United Health Products, Inc. (UEEC) — SEC Financial Statements & Analysis
United Health Products, Inc. (UEEC) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in NV. United Health Products, Inc. trades on OTC as: UEEC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), United Health Products, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.06x, a Price-to-Book (P/B) ratio of -3.36x (TTM), at a market cap of $14.91M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -1.06x
- P/B TTM
- -3.36x
- Market Cap
- $14.91M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is United Health Products, Inc. in?
United Health Products, Inc. (UEEC) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What is UEEC's market cap?
United Health Products, Inc. (UEEC) has a market capitalization of $14.91M as of 2026-06-30.
What exchange does UEEC trade on?
United Health Products, Inc. (UEEC) trades on the OTC.
Where is United Health Products, Inc. incorporated?
United Health Products, Inc. is incorporated in NV.